Ionis Pharmaceuticals is dramatically lowering the price of its blockbuster hopeful Tryngolza (olezarsen) as it prepares to ...

After attracting GSK with its subcutaneous delivery tech at the top of the year, South Korea’s Alteogen has snared another ...

Novartis is facing a class-action lawsuit alleging it shared, without patients’ consent, sensitive health information it ...

The FDA has approved Denali Therapeutics’ enzyme replacement therapy for a genetic lysosomal storage disease, breaking the ...

The FDA has given the all-clear to Corcept’s class-first Lifyorli (relacorilant) to treat adults with platinum-resistant ...

Healthcare professionals aren’t immune to societal shifts toward gathering information from artificial intelligence tools, social media and streaming content, opening up new opportunities for healt | ...

Takeda is setting the stage for a sweeping new round of restructuring, aiming to streamline operations to bankroll upcoming ...

Over the last seven months, Boehringer Ingelheim has gained approvals and label expansions in the U.S. for two of its newest ...

UCB plans to build a $2 billion manufacturing facility near its U.S. headquarters in Atlanta, Georgia. It will become the ...

A high-profile drug fraud case that could see the pharmaceutical industry thrown into the Racketeer Influenced and Corrupt ...

Despite policy uncertainties in recent years, WuXi Biologics’ emphasis on its U.S. operations continued to pay off in 2025, ...

The ‘90s sitcom “Full House” documented many of the ups and downs of growing up, including the often-excruciating experience ...